Meclopran Injection

Metoclopramide Hydrochloride
10mg
Lagap SA
Pack size 2ml Ampoule x 10
Dispensing mode POM
Source SWITZERLAND
AgentUnicare for Medical Trading
Retail Price 7.50 AED

Meclopran Overview

Meclopran generic name is Metoclopramide Hydrochloride. Metoclopramide Hydrochloride is a medication that is used to treat symptoms of gastrointestinal disorders such as nausea, vomiting, and acid reflux. It works by increasing the muscle contractions in the upper digestive tract which helps to move food through the stomach more quickly. It also helps to block the action of a chemical in the brain called dopamine, which can cause nausea and vomiting. Metoclopramide Hydrochloride is available as an oral tablet, injection and syrup form. Common side effects can include drowsiness, restlessness, and muscle spasms. It's important to take Metoclopramide Hydrochloride exactly as prescribed by your doctor and to follow the recommended dosage schedule. It should be used with caution in people with certain medical conditions such as Parkinson's disease, and should not be used in people who have a history of certain neurological conditions, such as tardive dyskinesia. It's also important to inform your doctor if you are pregnant, breastfeeding or planning to become pregnant.

Indications

Meclopran Injection is used for: Gastro-oesophageal reflux disease, Diabetic gastric stasis, Nausea and vomiting associated w/ cancer chemotherapy or radiotherapy, Postoperative nausea and vomiting

Adult Dose

Oral Diabetic gastric stasis Adult: 10 mg 4 times daily for 2-8 wk. Nausea and vomiting associated with cancer chemotherapy or radiotherapy Adult: 10 mg, up to tid. Max duration: 5 days. Gastro-oesophageal reflux disease Adult: 10-15 mg 4 times daily, depending on severity of symptoms. If symptoms are intermittent, may give single doses of 20 mg prior to provoking situation. Max duration: 12 wk. Elderly: 5 mg/dose. Parenteral Diabetic gastric stasis Adult: 10 mg 4 times daily by IM inj or slow IV inj over 1-2 min for up to 10 days. Convert to oral admin when symptoms subside sufficiently. Intravenous Prophylaxis of chemotherapy-induced nausea and vomiting Adult: For highly emetogenic drugs/regimens: Initially, 2 mg/kg by slow inj over at least 15 min, 30 min before chemotherapy. Repeat 2 hrly for 2 doses, then 3 hrly for 3 doses. For less emetogenic drugs/regimens: 1 mg/kg may be used. Max duration: 5 days. Premedication for radiologic examination of the upper gastrointestinal tract; Intubation of the small intestine Adult: 10 mg as a single dose by slow inj over 1-2 min. Parenteral Prophylaxis of postoperative nausea and vomiting Adult: 10 mg as a single dose by IM or slow IV inj over at least 3 min. Hepatic impairment: Severe: Reduce dose by 50%.

Child Dose

Small Bowel Intubation/Radiologic Examination of Upper GI Tract <6 years old: 0.1 mg/kg IV over 1-2 minutes 6-14 years old: 2.5-5 mg IV over 1-2 minutes >14 years old: 10 mg IV over 1-2 minutes Gastroesophageal Reflux Disease Neonate: 0.15 mg/kg IV q6hr Infant: 0.1 mg/kg IV/IM/PO q6-8hr 30 minutes before meals and at bedtime Not to exceed 0.3-0.75 mg/kg/day Diabetic Gastroparesis <6 years old: 0.1 mg/kg PO q8hr; not to exceed 0.1 mg/kg >6 years old: 0.5 mg/kg/day PO divided q8hr Postoperative Nausea & Vomiting 0.1-2 mg/kg IV q6-8hr PRN Chemotherapy-Induced Nausea & Vomiting 1-2 mg/kg IV (infused over at least 15 minutes) 30 minutes before chemotherapy; repeat q2-4hr; pretreatment with diphenhydramine decreases risk of extrapyramidal adverse effects

Renal Dose

Renal impairment: CrCl <40 mL/min, decrease dose by 50%; CrCl <10 mL/min, decrease dose by 75%

Administration

Should be taken on an empty stomach. Take ½ hr before meals. IV Administration NS is preferred diluent because drug is most stable in this solution Dose <10 mg: IV push over 1-2 minutes Dose >10 mg: Dilute in 50 mL D5W or NS, and infuse over at least 15 minutes

Contra Indications

Mechanical obstruction or GI perforation, GI haemorrhage; Confirmed or suspected pheochromocytoma; History of neuroleptic or metoclopramide-induced tardive dyskinesia; Epilepsy, Parkinson's disease; History of methaemoglobinaemia w/ metoclopramide or of NADH cytochrome-b5 deficiency. Concomitant use w/ levodopa or dopaminergic agonists.

Precautions

- Patients w/ underlying neurological conditions, cardiac conduction disturbances, uncorrected electrolyte imbalance, bradycardia. - Children, elderly. Renal or hepatic impairment, porphyria, epilepsy, Parkinson's disease, history of depression. - Ability to drive or operate machineries may be impaired. - Pregnancy and lactation. - Monitor patients on prolonged therapy. - Increased risk of tardive dyskinesia in patients on prolonged or high-dose treatment. Lactation: Drug crosses into breast milk; use caution; concern may be warranted according to American Academy of Pediatrics

Pregnancy-Lactation

Pregnancy Published studies, including retrospective cohort studies, national registry studies, and meta-analyses, do not report an increased risk of adverse pregnancy-related outcomes with use of metoclopramide during pregnancy. There are potential risks to neonate following exposure in utero to metoclopramide during delivery; in animal reproduction studies, no adverse developmental effects were observed with oral administration of metoclopramide to pregnant rats and rabbits at exposures about 6 and 12 times the maximum recommended human dose (MRHD) Metoclopramide crosses the placental barrier and may cause extrapyramidal signs and methemoglobinemia in neonates with maternal administration during delivery; monitor neonates for extrapyramidal signs Lactation Limited published data report the presence of metoclopramide in human milk in variable amounts; breastfed infants exposed to metoclopramide have experienced gastrointestinal adverse reactions, including intestinal discomfort and increased intestinal gas formation; metoclopramide elevates prolactin levels; however, published data are not adequate to support drug effects on milk production; developmental and health benefits of breastfeeding should be considered along with mother’s clinical need for therapy and any potential adverse effects on breastfed child from therapy or from underlying maternal condition Monitor breastfeeding neonates because metoclopramide may cause extrapyramidal signs (dystonias) and methemoglobinemia

Interactions

Increased sedative effects with CNS depressants. GI effects antagonised by antimuscarinics and opioids. Reduces absorption of digoxin. Increases absorption of ciclosporin, levodopa, aspirin, paracetamol. Interferes with hypoprolactinaemic effect of bromocriptine. Inhibits serum cholinesterase and prolongs neuromuscular blockade produced by suxamethonium and mivacurium. Potentially Fatal: Serotonin syndrome with sertraline (SSRI).

Adverse Effects

Side effects of Metoclopramide Hydrochloride : >10% Extrapyramidal symptoms (dystonic reactions in 25% of young adults 18-30 years old) 1-10% Restlessness (10%), Fatigue (2-10%), Sedation (10%), Headache (4-5%), Dizziness (1-4%), Somnolence (2-3%) Frequency Not Defined Diarrhea, Nausea, Gynecomastia, Galactorrhea, Impotence, Neuroleptic malignant syndrome, Menstrual disorders, Hematologic abnormalities Potentially Fatal: Neuroleptic malignant syndrome; Cardiac conduction disorders may occur with IV dosage form.

Mechanism of Action

Metoclopramide enhances the motility of the upper GI tract and increases gastric emptying without affecting gastric, biliary or pancreatic secretions. It increases duodenal peristalsis which decreases intestinal transit time, and increases lower oesophageal sphincter tone. It is also a potent central dopamine-receptor antagonist and may also have serotonin-receptor (5-HT3) antagonist properties.

Note

Meclopran 10mg Injection manufactured by Lagap SA. Its generic name is Metoclopramide Hydrochloride. Meclopran is availble in United Arab Emirates. Farmaco UAE drug index information on Meclopran Injection is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.

Some other brands of Metoclopramide Hydrochloride :

Syrup
Riamide 5mg/5ml
Riyadh Pharma (Medical and Cosmetic Products Company Ltd.)
Tablets
Pylomid 10mg
The Jordanian Pharmaceutical Manufacturing Company
Syrup
Premosan 5mg/5ml
Julphar (Gulf Pharmaceutical Industries)
Injection
Premosan 10mg/2ml
Julphar (Gulf Pharmaceutical Industries)
Drops (Oral)
Premosan 4mg/ml
Julphar (Gulf Pharmaceutical Industries)